AU2003905351A0 - Targets for Therapeutic Intervention - Google Patents

Targets for Therapeutic Intervention

Info

Publication number
AU2003905351A0
AU2003905351A0 AU2003905351A AU2003905351A AU2003905351A0 AU 2003905351 A0 AU2003905351 A0 AU 2003905351A0 AU 2003905351 A AU2003905351 A AU 2003905351A AU 2003905351 A AU2003905351 A AU 2003905351A AU 2003905351 A0 AU2003905351 A0 AU 2003905351A0
Authority
AU
Australia
Prior art keywords
targets
therapeutic intervention
intervention
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003905351A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Publication of AU2003905351A0 publication Critical patent/AU2003905351A0/en
Priority to AU2004267876A priority Critical patent/AU2004267876B2/en
Priority to EP04761204A priority patent/EP1667516A4/en
Priority to PCT/AU2004/001167 priority patent/WO2005020677A1/en
Abandoned legal-status Critical Current

Links

AU2003905351A 2003-08-29 2003-09-01 Targets for Therapeutic Intervention Abandoned AU2003905351A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2004267876A AU2004267876B2 (en) 2003-08-29 2004-08-27 Method of selecting animal models from animals which have been subject to mutagenesis, and the use of Myb transcription factors for screening
EP04761204A EP1667516A4 (en) 2003-08-29 2004-08-27 Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening
PCT/AU2004/001167 WO2005020677A1 (en) 2003-08-29 2004-08-27 Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening

Publications (1)

Publication Number Publication Date
AU2003905351A0 true AU2003905351A0 (en) 2003-10-16

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003901769A0 (en) Gaming system
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003215150A1 (en) Therapeutic compounds
AU2003216957A1 (en) System for bridge-laying
AU2003265375A1 (en) Novel targets for lithium therapy
AU2003905351A0 (en) Targets for Therapeutic Intervention
AU2003907191A0 (en) Targets for Therapeutic Intervention
AU2003904686A0 (en) Targets for Therapeutic Intervention
AU2003254043A1 (en) Antifungal therapeutic targets
AU2003260986A1 (en) Ear-pick for otoscopes
AU2003303963A1 (en) Drug target
GB0302315D0 (en) Novel therapeutic target
AU2003231937A1 (en) Therapeutic methods
AU2003246081A1 (en) Occlusion assist
AU2003296273A1 (en) Neutron-producing target device
AU2003902516A0 (en) Therapeutic compositions - II
AU2003271237A1 (en) Therapeutic brassiere
AU2003280821A1 (en) Beauveriolide derivative
AU2003900010A0 (en) Target for lymphoproliferative disorders ii
AU2003900496A0 (en) Aroylhydrazone derivatives therapeutic uses thereof
AU2004907275A0 (en) Therapeutic compounds
AU2004907252A0 (en) Therapeutic compounds
AU2003905461A0 (en) Therapeutic method
AU2003900009A0 (en) Target for lymphoproliferative disorders I
AU2004904834A0 (en) Therapeutic Method - II